United States Tissue Engineered - Skin Substitutes Market Outlook to 2024

  • ID: 4394254
  • Report
  • Region: United States
  • 71 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • Baxter International Inc
  • C. R. Bard Inc
  • CryoLife Inc
  • Ethicon US LLC
  • Integra LifeSciences Corp
  • MORE
United States Tissue Engineered - Skin Substitutes Market Outlook to 2024

Summary

The new report, "United States Tissue Engineered - Skin Substitutes Market Outlook to 2024", provides key market data on the United States Tissue Engineered - Skin Substitutes market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Biologic Skin Substitutes, Biosynthetic Skin Substitutes and Synthetic Skin Substitutes.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope
  • Market size and company share data for Tissue Engineered - Skin Substitutes market segments - Biologic Skin Substitutes, Biosynthetic Skin Substitutes and Synthetic Skin Substitutes.
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the United States Tissue Engineered - Skin Substitutes market.
  • Key players covered include Ethicon US LLC, Baxter International Inc, Integra LifeSciences Corp and C. R. Bard Inc.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Baxter International Inc
  • C. R. Bard Inc
  • CryoLife Inc
  • Ethicon US LLC
  • Integra LifeSciences Corp
  • MORE
1 Table of Contents
2 Introduction
2.1 What Is This Report About?
2.2 Tissue Engineered - Skin Substitutes Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Tissue Engineered - Skin Substitutes Market, United States
3.1 Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), 2010-2017
3.2 Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), 2017-2024
3.2.1 Biologic Skin Substitutes Market, United States, Revenue ($m), by Segment, 2010-2017
3.2.2 Biologic Skin Substitutes Market, United States, Revenue ($m), by Segment, 2017-2024
3.3 Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), 2010-2017
3.4 Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), 2017-2024
3.4.1 Biologic Skin Substitutes Market, United States, Volume (Units), by Segment, 2010-2017
3.4.2 Biologic Skin Substitutes Market, United States, Volume (Units), by Segment, 2017-2024
3.5 Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), 2010-2024
3.6 Tissue Engineered - Skin Substitutes Market, United States, Distribution Share by Revenue ($m), 2017
3.7 Tissue Engineered - Skin Substitutes Market, United States, Company Share by Revenue ($m), 2017
4 Overview of Key Companies in United States, Tissue Engineered - Skin Substitutes Market
4.1 Ethicon US LLC
4.1.1 Company Overview
4.2 Baxter International Inc
4.2.1 Company Overview
4.3 C. R. Bard Inc
4.3.1 Company Overview
4.4 CryoLife Inc
4.4.1 Company Overview
4.5 Integra LifeSciences Corp
4.5.1 Company Overview
5 Tissue Engineered - Skin Substitutes Market Pipeline Products
6 Financial Deals Landscape
6.1 Acquisition
6.1.1 Allergan Acquires LifeCell from Acelity for USD2.9 Billion
6.2 Equity Offerings
6.2.1 RenovaCare Raises USD1 Million in Private Placement of Units
6.2.2 Biostage Raises USD8 Million Public Offering of Shares
6.3 Partnerships
6.3.1 Progenerative Medical Enters into Licensing Agreement with Kinetic Concepts
6.4 Venture Financing
6.4.1 Saba Labs Raises USD0.3 Million in Venture Financing
6.4.2 Organogenesis Raises USD20 Million in Venture Financing
7 Recent Developments
7.1 Corporate Communications
7.1.1 Jul 27, 2017: Anika Announces Appointment of Joseph Darling as President
7.1.2 Jun 09, 2017: Acera Surgical appoints new board member
7.1.3 Apr 18, 2017: Biostage Appoints Stephen F. Badylak DVM, PhD, MD, as Co-Chairman of Scientific Advisory Board
7.1.4 Mar 19, 2017: MiMedx Announces The Addition Of Luis A. Aguilar To Its Board Of Directors
7.1.5 Sep 19, 2016: Organogenesis Announces New Chief Financial Officer
7.2 Financial Announcements
7.2.1 Aug 14, 2017: Biostage Reports 2017 Second Quarter Financial Results
7.2.2 Jul 26, 2017: MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance
7.2.3 Jul 26, 2017: Anika Reports Strong Second Quarter 2017 Financial Results
7.2.4 Jul 13, 2017: MiMedx Announces that its Second Quarter Revenue Exceeds the Guidance Range
7.2.5 May 11, 2017: Biostage Reports 2017 First Quarter Financial Results and Provides Business Update
7.2.6 May 03, 2017: Anika Reports First Quarter 2017 Financial Results
7.2.7 Apr 28, 2017: MiMedx Announces Record Results For First Quarter Of 2017
7.2.8 Apr 13, 2017: MiMedx Announces First Quarter 2017 Revenue to Exceed High End of Guidance
7.2.9 Mar 09, 2017: Biostage Reports 2016 Financial Results and Provides Business Update
7.2.10 Feb 23, 2017: MiMedx Announces 2016 Record Results
7.2.11 Feb 15, 2017: Anika Reports Fourth Quarter and Full Year 2016 Financial Results
7.2.12 Feb 15, 2017: Anika Therapeutics Reports 33% Revenue Growth in Third Quarter 2011
7.2.13 Jan 09, 2017: MiMedx Fourth Quarter 2016 Revenue in Upper Range of Guidance
7.2.14 Dec 16, 2016: MiMedx 2017 Guidance Forecasts Revenue Growth In Excess Of 21% And Operating Earnings Growth In Excess Of 90%
7.2.15 Nov 10, 2016: Biostage Reports 2016 Third Quarter Financial Results and Provides Business Update
7.2.16 Oct 27, 2016: MiMedx Announces Third Quarter 2016 Results
7.2.17 Oct 26, 2016: Anika Reports Third Quarter 2016 Financial Results
7.2.18 Oct 10, 2016: MiMedx Third Quarter 2016 Revenue Exceeds Upper End of Guidance
7.3 Other Significant Developments
7.3.1 Jul 05, 2017: MiMedx Agreement With AvKARE Expires As Planned Following Completion Of Contract Wind-Down
7.3.2 Sep 06, 2016: MiMedx Reaffirms Q3 and Full Year 2016 Guidance
7.4 Product News
7.4.1 Nov 03, 2016: MiMedx Announces USP-NF Monograph For dHACM Allografts Has Published
7.4.2 Sep 12, 2016: Scientific Study Confirms How MiMedx dHACM Allografts Effectively Promote Wound Repair
8 Appendix
8.1 Research Methodology
8.1.1 Coverage
8.1.2 Secondary Research
8.1.3 Primary Research
8.1.4 Market Modeling and Forecasting
8.1.5 Company Share Analysis
8.1.6 Distribution Share Analysis
8.1.7 Benchmarking
8.2 Consulting
8.3 Contact
8.4 Disclaimer

List of Tables
Table 1: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 2: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 3: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Table 4: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Table 5: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Historic, 2010-2017
Table 6: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Forecast, 2017-2024
Table 7: Biologic Skin Substitutes Market, United States, Volume (Units), Historic, 2010-2017
Table 8: Biologic Skin Substitutes Market, United States, Volume (Units), Forecast, 2017-2024
Table 9: Tissue Engineered - Skin Substitutes Market, United States, Average Price ($) Historic, 2010-2017
Table 10: Tissue Engineered - Skin Substitutes Market, United States, Average Price ($), Forecast, 2017-2024
Table 11: Tissue Engineered - Skin Substitutes Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017
Table 12: Tissue Engineered - Skin Substitutes Market, United States, Company Share by Revenue ($m), USD Constant, 2017
Table 13: Tissue Engineered - Skin Substitutes Market Pipeline Products
Table 14: Allergan Acquires LifeCell from Acelity for USD2.9 Billion
Table 15: RenovaCare Raises USD1 Million in Private Placement of Units
Table 16: Biostage Raises USD8 Million Public Offering of Shares
Table 17: Progenerative Medical Enters into Licensing Agreement with Kinetic Concepts
Table 18: Saba Labs Raises USD0.3 Million in Venture Financing
Table 19: Organogenesis Raises USD20 Million in Venture Financing
Table 20: Total Number of Primary Research Participants, Wound Care Management Market, by Country

List of Figures
Figure 1: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 2: Tissue Engineered - Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 3: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017
Figure 4: Biologic Skin Substitutes Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024
Figure 5: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Historic, 2010-2017
Figure 6: Tissue Engineered - Skin Substitutes Market, United States, Volume (Units), Forecast, 2017-2024
Figure 7: Biologic Skin Substitutes Market, United States, Volume (Units), Historic, 2010-2017
Figure 8: Biologic Skin Substitutes Market, United States, Volume (Units), Forecast, 2017-2024
Figure 9: Tissue Engineered - Skin Substitutes Market, United States, Company Share (%) 2017
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Ethicon US LLC
  • Baxter International Inc
  • C. R. Bard Inc
  • CryoLife Inc
  • Integra LifeSciences Corp
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll